Amphastar Pharmaceuticals AMPH Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Finished Pharmaceutical Products | $171.17M+0.4% | —— | $191.84M+0.3% | $174.41M-4.4% | $170.53M-0.8% | |
| Pharmaceutical Products | $171.17M+0.4% | —— | —— | —— | $170.53M-0.8% | |
| Revenue by Geography | ||||||
| CN | $2.48M+2,964% | $925K-57.8% | $1.88M+956% | $299K-80.9% | $81K-79.9% | |
| FR | $9.65M+22.8% | $10.63M+15.0% | $9.68M+114% | $7.11M+61.3% | $7.86M+342% | |
| US | $159.04M-2.2% | $171.55M-2.0% | $180.28M-3.3% | $167M-5.3% | $162.59M-4.2% | |
| Non-Current Assets by Geography | ||||||
| CN | $108.56M-1.7% | $110.06M+2.0% | $109.64M+6.4% | $110.41M+15.2% | $110.48M+17.8% | |
| FR | $35.32M+1.0% | $36.97M+7.4% | $36.89M-0.6% | $37.29M+4.1% | $34.99M-4.6% | |
| US | $235.03M+12.8% | $206.7M+2.2% | $207M+10.5% | $207.03M-72.6% | $208.3M-72.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Amphastar Pharmaceuticals break its business down?
- Amphastar Pharmaceuticals (AMPH) reports revenue by business across 2 parts — Finished Pharmaceutical Products and Pharmaceutical Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Amphastar Pharmaceuticals's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Amphastar Pharmaceuticals's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
